A B S T R A C T Five patients received cholesterol7a-3H intravenously during control periods. Specific activity of total serum cholesterol was determined serially during the 1st wk and weekly thereafter. 28-59 wk after the injection of the tracer, when no further radioactivity could be detected in serum cholesterol, 2 g of oral neomycin was given daily to four patients for the remainder of the experiment. Average total serum cholesterol concentrations were reduced by 20, 21, 26, and 29%, respectively, in these subjects. The fifth patient, given placebo, had no change in serum cholesterol. After a period of 12-26 wk of medication the intravenous injection of cholesterol7a-3H was repeated, and while neomycin or placebo administration was continued, serum cholesterol specific activity was again determined serially during the 1st wk and weekly thereafter for 23-42 wk. The data were subjected to a twocompartment analysis. During the administration of neomycin, half-times of the cholesterol radioactivity decay curves were decreased in two patients and remained unchanged in two subjects.
A B S T R A C T Five patients received cholesterol7a-3H intravenously during control periods. Specific activity of total serum cholesterol was determined serially during the 1st wk and weekly thereafter. 28-59 wk after the injection of the tracer, when no further radioactivity could be detected in serum cholesterol, 2 g of oral neomycin was given daily to four patients for the remainder of the experiment. Average total serum cholesterol concentrations were reduced by 20, 21, 26 , and 29%, respectively, in these subjects. The fifth patient, given placebo, had no change in serum cholesterol. After a period of 12-26 wk of medication the intravenous injection of cholesterol7a-3H was repeated, and while neomycin or placebo administration was continued, serum cholesterol specific activity was again determined serially during the 1st wk and weekly thereafter for [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] wk. The data were subjected to a twocompartment analysis. During the administration of neomycin, half-times of the cholesterol radioactivity decay curves were decreased in two patients and remained unchanged in two subjects. INTRODUCTION Several regimens and a few pharmacologic agents are available to reduce the concentration of serum cholesterol in man. The theoretical justification of lowering the level of serum cholesterol is the assumption that, concomitantly, the amount of cholesterol in the body will be reduced, particularly the amount of cholesterol deposited in atheromas. This, however, is by no means a necessary consequence of serum cholesterol reduction (2, 3) , and the decrease or increase of the size of different body pools of cholesterol may depend on the mechanisms of action involved with each agent. The reduction of the concentration of serum cholesterol may occur in any of the following ways: (a) decreased biosynthesis; (b) decreased intake or absorption; (c) increased excretion of neutral steroids or bile acids; (d) shifting of cholesterol from the "serum pool" into "another pool" in the body (red blood cells, liver, other organs, muscles, intima of blood vessels, nervous system tissue, etc.), or any combination of these. It has been reported (4) (5) (6) (7) (8) (9) that the daily oral administration of 0.5-2 g of neomycin sulfate significantly reduced the concentration of serum cholesterol in man. This reduction is accompanied by a three to fivefold increase in the fecal excretion of bile acids (7, 8) and a twofold increase in the fecal excretion of neutral steroids (8) during the non-steady state, a finding which suggests the involvement of pathway (c). In the present study, data are presented on the effect of the administration of neomycin in man on the time course of decay of serum cholesterol specific activity for periods up to 42 wk. The data are interpreted in terms of a two-compartmental model.
METHODS
Experimental. Five patients, two males and three females, were studied. The age range was 45-62 yr. The clinical diagnoses are included in Table I . All patients were ambulatory, their respective diseases under good control, and three of the five were working at their regular jobs during the study. Medications other than experimental were kept constant, and substances known to influence serum cholesterol levels were not given. The diet was uncontrolled, but the patients were instructed to adhere to their customary diets. The patients were seen weekly, with the exception of a few appointments that were missed (vacations, family, job engagements, or other reasons). They were weighed weekly, and physical examination, blood counts, test of urine, blood urea nitrogen, blood sugar, serum bilirubin, serum transaminases, cephalin flocculation, and stool culture for pathogens were carried out periodically. Cholesterol-7a-'H (New England Nuclear Corp., Boston, Mass.) (225 /sc/mmole) was purified by thinlayer chromatography (10) . About 20 ml of blood was drawn from each subject 4-6 days before the injection of the tracer, and the serum was separated aseptically and stored at 4VC. An appropriate amount of cholesterol7a-8H was dissolved in 0.5 ml of ethanol, and 0. was given intravenously to each subject. There were no reactions to the injection of the tracers. The results of the rate of incorporation of labeled acetate into serum cholesterol will be presented elsewhere. After the injection of the tracer, blood was drawn serially during the 1st wk (average number of samples, 7.7 during the 1st wk) and weekly thereafter in the fasting state. Total serum cholesterol concentrations were determined in each sample by the method of Abell, Levy, Brodie, and Kendall (11) . A separate 3 ml aliquot of the serum was saponified by the addition of 28 ml of ethanol and 2 ml of 33% KOH solution. After the addition of an equal volume of water, neutral steroids were extracted four times with equal volumes of hexane. There was no hexane-extractable radioactive material left in the ethanolwater layer. The combined hexane extracts were washed with water, the hexane was evaporated, and the residue was dissolved in toluene. Parallel determinations of specific radioactivity were identical when this procedure was compared to a procedure involving digitonide precipitation of sterols. Specific activity was measured in a Tri-Carb liquid scintillation spectrometer, with toluene solution containing 4 mg of 2,5-diphenyloxazole and 0.3 mg of 1,4-bis-2-(5-phenyloxazolyl)-benzene per ml. All samples were counted in the range from 10' to 106 counts. The least radioactive samples, of the order of 100 cpm, were counted to 10' counts, and the long-term follow-up of radioactivity was terminated at this point. The samples were recounted after the addition of known internal standards for 3H and 14C activity (in 0.1 ml of toluene each). After correction for quenching, specific activity was calculated in disintegrations per minute (12) . 28 -59 wk after the injection of the tracer, when no further radioactivity (of the order of 100 cpm) could be detected in serum cholesterol, 2 g of neomycin sulfate was given daily by mouth to four patients. The fifth subject was given placebo to control the reproducibility of the tracer methods. After a period of 12-26 wk of neomycin or placebo administration, 31-42 uc of cholesterol-7a-'H (and 100 uc of sodium acetate-1-"C) was injected intravenously for the second time, and while medication was continued, the sequence of procedures outlined above was repeated. Weekly determinations of serum total cholesterol specific activities were carried out for 23-42 wk after the injection of the tracer in both control and medication experiments. The time interval between the two injections of tracer was 44-76 wk. Fig. 1 plotted semilogarithmically against time (Figs. 2-6 ).
Two exponentials, a1'e-'i' and a2'e-e2', were curve-fitted to each plot by the conventional graphical "peeling-off" process, as described in the legend to Fig. 2a . Each exponential is characterized by an amplitude or coefficient a,' (% g1-) and a half-life (ti)4 (day). The half-life is converted to the exponent factor ai(day') by the relation a = 0.693/(tI),. The subscript i = 1 denotes the "intermediate" exponential and the subscript i = 2 denotes the "slow" or smallest exponential. The sum of the two derived exponentials (Appendix, equation 11) fitted the data satisfactorily from approximately 0.5 day to the longest time of measurement.' From the earliest measured value (2 hr after injection of tracer) to about 0.5 day, a relatively rapid decrease of serum specific activity occurred which could not be fitted by the sum of two exponentials (Fig. 2 b) . Since the measurements were scanty in this time interval and since, moreover, the process of exchange of tracer cholesterol between the serum and the various body pools is complicated initially by the interconversion between free and esterified tracercholesterol, the data in this time interval were not curvefitted and analyzed.
After Goodman and Noble (13), the two-exponential fit of the data from 0.5 day to the longest measured time was analyzed by a two-compartment model, defined as follows ( Fig. 7 1 The data, curve-fitting method, and closeness of curve fit were similar to those of Goodman and Noble (13) . These authors compared their manual curve-fitting method with a computerized least squares method and concluded that there was little difference in the exponential parameters derived by either method. Their conclusion therefore applies also to the present results.
with the experiment have been developed (17) (18) (19) . In an effort to extract maximum information from the present experiment such a survey has been made, with a variation of the mathematical method of Skinner, Clark, Baker, and Shipley (19) . There are eight compartment parameters (six rates and two pool sizes, Fig. 7 ). The experiment yields four exponential parameters (two amplitudes and two exponent factors) which by the tracer-kinetic relations (Appendix) yield four conditions on the compartment parameters. The steady-state relations on nontracer cholesterol flow through each compartment yield two more conditions. Hence the present problem has two degrees of freedom (18) , that is, two more conditions must be specified in order to derive the eight compartment parameters. These two conditions will be taken herein as specification of the input-rate ratio ( = Ib/Ia and the output-rate ratio q = Eb/E2. The survey of compartment parameters compatible with the present experiment is then made in terms of 4 and 7 as survey parameters. The significance of this choice is that the extreme values 0 and oo for E and also for X turn out to yield maximum or minimum values of the individual compartment parapneters; (the extent to which this is true for other choices of survey parameters is not known [18, 19] ). Thus the survey of compartment parameters is made simply by solving four so-called limit cases (Appendix), those for which (Q, q) = (0, 0), (0, 00), (00, 0), and (00, 00). The true value of any compartment parameter must then be intermediate between the extreme values given by these limit cases.
RESULTS
During the oral administration of neomycin, average total serum cholesterol concentrations fell by 29, 26, 21, and 20%, respectively, in the four patients studied. The differences were statistically significant at the 0.1% level. The reduction of serum cholesterol in these patients was comparable to previous results (4) (5) (6) (7) (8) (9) . In the fifth patient given placebo, there was no change in the level of serum cholesterol (Table I ). Fig. 1 shows the serum cholesterol concentrations of one patient. The administration of the drug was well tolerated. During the first 2 wk of the administration of neomycin two of the four patients experienced temporary loose bowel movements and abdominal cramps. The administration of neomycin was continued, and the symptoms subsided spontaneously by the end of the 2nd wk. These findings are again comparable to previous experience with the use of this drug in this laboratory (4) (5) (6) 9) . No other side effects were noted, the weight of the patients remained constant within 2 lbs variation, and physical examinations and the monitoring laboratory studies remained unchanged during the ad- ministration of the drug. When the second tracer dose was given, the level of serum cholesterol was at a lower plateau (Fig. 1) , in a steady state, and the patients were completely free of side effects.
Figs. 2-6 compare the decay curves of radioactivity during control periods and during the administration of neomycin. The solid and dashed curves in Fig. 2 a represent the computed sum of two exponentials and illustrate the closeness of fit to the data for t > 0.5 day. Figure 2 b shows the initial rapid fall of specific activity for t < 0.5 day. This portion of the data is -not represented by the sum of two exponentials.
The exponential parameters, namely, the amplitudes a,', a2' and the exponential factors a1 a2 and equivalent half-lives (tj)1, (ti)2 of the two exponentials curve-fitted to each decay curve, are given in Table II . Of the four patients receiving neomycin, the half-lives decreased in two and remained unchanged in two. There was no discernible change in the half-lives of the patient given placebo.
The previously enumerated combinations of compartment parameters which can be derived uniquely from the exponential parameters by compartment analysis are given in Table III decreases of Ma which were 13, 15, 18, and 9 g, respectively.
Compartment parameter survey calculations were made for all subjects. The results for subject H.F. are given in Table IV . These results were obtained from the model solutions for the limit cases (Appendix), listed in nondimensional form in Table V (Fig. 7) are established by case 4; (b) the large percentage increases in total and fractional turnover rates upon neomycin administration to subject H.F. (Table III) are due, generally speaking, to constancy of the input, output, and exchange rates while both pool sizes decreased. Similar calculations for subject S.S. showed that the various rates changed upon neomycin administration in about the same proportion as the pool sizes, and thus the turnover rates remained approximately unchanged (Table III) by the two-compartment analysis of the present customary initial labeling assumption involves experiment only if the initial conditions, that is, the some error. This error was investigated by making amounts of tracer in compartments a and b at time an approximate fit of a third exponential to the zero, are known. The customary assumption (13) available data from 2 hr after injection to 0.5 day was made herein that all the injected tracer is in and by making a three-compartment analysis compartment a at time zero. Since, however, the analogous to that previously described, in which tracer was injected into the blood, all tissues the third or "fast" compartment was considered to would have some access to tracer in the initial be the blood serum. Although this analysis was in half day during which the tracer exists in blood at error because it did not distinguish between the specific activities in excess of those given by the free and esterified forms of cholesterol in the initial two-exponential curve fit. Moreover, tracer would interval, the analysis was thought to contain the be lost from the system during this initial "high essential features neglected in the initial labeling specific activity interval" in excess of that allowed assumption of the two-compartment analysis. The for by extrapolating the two-exponential curve fit results indicated that the present two-compartfrom 0.5 day back to time zero. Evidently the ment values of M. are overestimated by some day-' 
DISCUSSION
The rate of disappearance of labeled cholesterol from the serum has been studied extensively. It has been pointed out that in humans the decay of labeled cholesterol in the plasma proceeds at a series of decreasing exponential rates for periods as long as 50 days (20) . Similar observations were made in rats (21) . However, reports from a number of laboratories demonstrated that in man after about 8-10 wk the decay of specific activity proceeds at a single exponential rate and yields a straight line when plotted semilogarithmically (22) (23) (24) . The rapid decrease of the initial portion of the decay curves is thought to be due in part to cholesterol transformation or excretion which represents cholesterol turnover, and in part to a molecular interchange between the cholesterol of serum and cholesterol of other tissues (25) . The possibility of a significant return into the serum compartment of labeled cholesterol deposited at earlier times in other tissue pools has been suggested (21) . The two-compartment model in the present study reflects these considerations. Exponential half-lives were calculated by a number of authors on cholesterol decay curves in short-term experiments. On the initial portion of the curves, when the decay of radioactivity proceeds at decreasing exponential rates, London and Rittenberg (26) found half-lives of 6 days. Hellman, Rosenfeld, and Gallagher (20) (Table II) . In long-term studies, halflives of the slowest exponentials were found to be 69-74 days by Kurland, Lucas, and Freedberg (23), and 58-100 days by Chobanian, Burrows, and Hollander (24) . Here also, the order of magnitudes are in agreement with those of the slowest exponentials (ti)2 in the present study (Table II) .
During the administration of neomycin, corresponding half-liveA decreased in two patients and remained unchanged in two subjects (Table II) . It should thus be emphasized that the calculated intermediate pool size can decrease during the administration of neomycin (Table III) in the presence of both unchanged or decreased half-lives. The semilogarithmic plot of the present data did not show any significant deviation from linearity during the duration of this experiment, namely up to 42 wk. This point indicates that up to this time there was no suggestion in the data of a more slowly exchangeable pool of cholesterol.
In scrutinizing for the possible uncertainties of interpretation in the present analysis, two distinct possibilities should be mentioned. First, chemical or biological reproducibility; however, the data of the radioactive decay curves in the patient given placebo were consistently identical during control and placebo periods. The two series of tests (control and placebo) in this patient were carried out with a 66 wk interval from each other, and the analytical procedures covered 32 wk in each instance. The second possible uncertainty concerns the deduction of compartment parameters from the data. The injected tracer cholesterol was in the free form, whereas the measured specific activities were of total cholesterol. It is known that equilibration between free and ester forms of cholesterol in plasma is completed in from 2 to 5 days (20, (28) (29) (30) . Since the intermediate half-life in the present experiments ranged from 5 to 8 days (Table II) , it is evident that some error must be involved in failing to distinguish between free and esterified cholesterol in the first few days after injection~T his error is probably not serious, however, since the main time region during which the intermediate exponential decays is approximately four half-lives or 20-30 days (Figs. 2-6 ). During most of this interval the total tracer cholesterol would be present in all tissues in essentially equilibrium proportions between free and esterified forms so that the compartment parameters are legitimately derived in terms of equivalent total cholesterol. It is also noted that no significant deviation from the fitted sum of two exponentials was apparent down to approximately 0.5 day (Fig. 2 a) , although substantial interchange between free and esterified forms of serum tracer cholesterol must have been occurring from 0.5 to 2 days. Thus, to the extent that the intermediate exponential in its later time stages characterizes interchange of an equilibrated mixture of free and esterified tracer, the curve fit down to 0.5 day would indicate that the changes due to the initially nonequilibrium distribution are not serious for present purposes.
In addition to the preceding uncertainty, it is well known that from the data presented the individual compartment parameters (Fig. 7) other than intermediate pool size M. cannot be determined uniquely. However, a range of possible values can be deduced for each parameter (Table  IV) . It is of interest to note that the input and output rates of all the cases are within the range of values obtained by direct analysis of fecal cholesterol end products (2, 3) (see production rate [13] in Table III) .
The control exponential parameters for the clinically "normal" subjects A.F. and E.A., (both free of clinical evidence of atherosclerosis) (Table  II) are in good agreement with those obtained by Goodman and Noble (13) for their normal subjects. Since the two-compartment model used by these authors is the same as that adopted here, the present deductions as to control compartment parameters for the clinically normal subjects are in general agreement with those of Goodman and Noble (13 (16, 17) are (Fig. 7) dya/dt = -Ay. + Byb [1] dyb/dt = Cy, -Dyb [2] in which ya, yb ( C = rb/Ma. [6] The two independent steady-state conditions for nontracer cholesterol transport may be expressed as Ia + Ib = E. + Eb Ia + rba = Ea + rab- [7] [8]
The initial conditions correspond to injection at time zero of the amount yao of tracer into compartment a and no tracer into compartment b, or Ya(O) = YaO, yb(O) = 0.
[9]
The solution of equations 1, 2 for compartment a is of the form yG(t) = ale--,' + a2e-C2t.
The experimental data are expressed as 100 y,(t)/Myo = aile alt + a2'e-a2t [11] where yo is the amount of tracer injected. At time t = 0 equation 11 gives M. = 100 (yao/yo)(ai' + a2')-l. [12] Since the injected amount of tracer yo is identified in the present analysis as the amount yao initially in compartment a, equation 12 becomes M. = 100/(al' + a2').
[ 13] In addition to M., the three other quantities yielded uniquely by the compartment analysis are obtained from equations 1, 2, 10 as (14-17) [14] [ Eb/MOA = n(1 -u) [10] [26] [27] [28]
Ia/MaA = (1 + t)-'(1 + X) (1 -u) Ib/IMfaA = t(1 + t)-'(1 + n) (1 -u) rba/MGA = u + (1 + t)-1(t -n)(1 -u) [29] M., Mb, g, amounts of body cholesterol in compart- [30] ments a, b respectively, (MA, MB)-ra,, g day-', rate of transfer of body cholesterol from [31] MbD/M0A = (1 + t)-'[(1 -W)u + t(1 + 1)] [32] The limit case solutions are obtained by going to the appropriate limits t, t -0 or x in equations 23-25. These solutions are tabulated in Table V . Together with the values for subject H.F. in Table III , they yielded the results in Table IV . Case 5 in Table IV It is noteworthy (13, 15) that the production rate does not depend on Xq = Eb/E., that is, it is uniquely determined by the present experimental data as expressed in Table III. Another such quantity is (E.)Eb-0o = (Ia + Ib)EbO which is also given by equation 33.
PRINCIPAL SYMBOLS (Symbols in parentheses are the equivalent symbols of Goodman and Noble [13] ).
al, a2, dpm, exponential amplitudes of "fast" and "slow" exponentials, respectively, in Appendix equation 10, (MACA, MACB).
a,', a2l, co g-, "peeled-off" exponential amplitudes of "fast" and "slow" exponentials, Appendix equation 11, (100 CA/RA) (100 CB/RA).
al, a2, day-', "fast" (greater) and "slow" (lesser) exponent factors derived from "peeled-off" exponential half-lives, Appendix equation 1 1 (cr, A). A, day-', total turnover rate of compartment a,
